3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Phase 2
1
Status
Terminated
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
CNS
2
Conditions
Neurofibromatosis 1
2
Pain
1
Noonan Syndrome
1
Neurotoxicity Syndromes
1
Cognition Disorders
1
Interventions
AZD 6244
9
Lovastatin
5
Deoxycholic Acid
4
trametinib
3
Lasers, Solid-State
3
mirdametinib
2
fludarabine
2
Transcranial Direct Current Stimulation
2
Sirolimus
2
Polidocanol
2
Magnetic Resonance Imaging
2
Lasers
2
Lamotrigine
2
Inhalation
2
Acetylcysteine
2
thymoglobulin
1
talimogene laherparepvec
1
peginterferon alfa-2b
1
gadolinium compound P760
1
fludarabine phosphate
1
diphenylcyclopropenone
1
cabozantinib
1
binimetinib
1
X-Rays
1
Vitamin D
1
Vincristine
1
Vinblastine
1
Temozolomide
1
Surgical Procedures, Operative
1
Sunitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Neurofibromatosis 1
×
Lamotrigine
×
Clear all
NCT03504501
2023-11-30
SynCoRAS
Technical University of Munich
Phase 2
Terminated
16 enrolled
NCT02256124
2020-04-14
NF1-EXCEL
Erasmus Medical Center
Phase 2/3
Terminated
41 enrolled